Table 4.
Comparison of svPPA with healthy controls and AD on MTL subregional volumes (in mm3; parahippocampal subregions are corrected for slice number; ICV is regressed out for all variables)
svPPA | Control | svPPA | svPPA vs Control | AD | AD | svPPA vs AD | AD vs Control | |
---|---|---|---|---|---|---|---|---|
Left | Mean±SD | Mean±SD | % of Control | p-value | Mean±SD | % of Control | p-value | p-value |
N | 12 | 23 | 36 | |||||
CA1 | 831±129 | 1328±126 | −37.4 | <0.001 | 1043±219 | −21.5 | 0.002 | <0.001 |
DG | 612±72 | 826±107 | −25.9 | <0.001 | 664±119 | −19.7 | 0.068 | <0.001 |
SUB | 370±44 | 436±44 | −15.2 | <0.001 | 390±69 | −10.7 | 0.220 | 0.012 |
ERC | 15.7±3.4 | 21.1±2.5 | −25.9 | <0.001 | 18.8±4.2 | −11.3 | 0.032 | 0.012 |
BA35 | 9.8±3.9 | 21.2±4.0 | −53.8 | <0.001 | 16.3±4.8 | −23.3 | <0.001 | <0.001 |
BA36 | 33.0±10.6 | 71.5±12.2 | −53.8 | <0.001 | 63.2±17.4 | −11.6 | <0.001 | 0.076 |
PHC | 42.1±9.1 | 55.3±9.6 | −23.9 | 0.001 | 45.4±9.4 | −17.9 | 0.283 | 0.001 |
Right | Mean±SD | Mean±SD | % of Control | p-value | Mean±SD | % of Control | p-value | p-value |
N | 14 | 23 | 37 | |||||
CA1 | 1157±208 | 1399±138 | −17.3 | <0.001 | 1133±210 | −19.0 | 0.626 | <0.001 |
DG | 747±126 | 851±94 | −12.2 | 0.010 | 666±109 | −21.7 | 0.049 | <0.001 |
SUB | 403±50 | 438±42 | −8.1 | 0.033 | 393±72 | −10.4 | 0.535 | 0.003 |
ERC | 19.4±4.8 | 22.2±3.4 | −12.6 | 0.062 | 19.6±3.8 | −11.9 | 0.916 | 0.011 |
BA35 | 16.9±5.9 | 21.3±2.6 | −20.6 | 0.002 | 17.6±4.5 | −17.4 | 0.447 | 0.001 |
BA36 | 46.3±16.4 | 69.4±11.7 | −33.2 | <0.001 | 64.8±17.2 | −6.6 | 0.002 | 0.194 |
PHC | 56.5±12.9 | 62.2±9.7 | −9.2 | 0.156 | 49.7±11.5 | −20.2 | 0.083 | <0.001 |
Bolded p-values are significant after the Holm-Bonferroni correction. svPPA=semantic variant Primary Progressive Aphasa; AD=Alzheimer’s disease; CA=cornu ammonis; DG=dentate gyrus; SUB=subiculum; ERC=entorhinal cortex; BA=Brodmann area; PHC=parahippocampal cortex